Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-Hydroxy-5,8-dimethoxyquinoline-3-carbonitrile is a complex organic compound characterized by a quinoline ring structure, which is a fused six-membered aromatic ring system. This particular compound features a hydroxyl group (-OH) at the 4-position, two methoxy groups (-OCH3) at the 5 and 8 positions, and a nitrile group (-CN) at the 3-position. The presence of these functional groups endows the molecule with unique chemical properties and potential applications in various fields, such as pharmaceuticals and agrochemicals, where it may serve as an intermediate in the synthesis of more complex molecules. The compound's structure and functional groups also suggest that it could have interesting reactivity patterns and may be involved in various chemical transformations.

61338-35-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 61338-35-0 Structure
  • Basic information

    1. Product Name: 4-hydroxy-5,8-dimethoxyquinoline-3-carbonitrile
    2. Synonyms: 4-Hydroxy-5,8-dimethoxychinolin-3-carbonitril; 5,8-Dimethoxy-4-oxo-1,4-dihydrochinolin-3-carbonitril; 5,8-dimethoxy-4-oxo-1,4-dihydroquinoline-3-carbonitrile
    3. CAS NO:61338-35-0
    4. Molecular Formula: C12H10N2O3
    5. Molecular Weight: 230.2194
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 61338-35-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 461.4°C at 760 mmHg
    3. Flash Point: 232.9°C
    4. Appearance: N/A
    5. Density: 1.36g/cm3
    6. Vapor Pressure: 3.89E-09mmHg at 25°C
    7. Refractive Index: 1.642
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 4-hydroxy-5,8-dimethoxyquinoline-3-carbonitrile(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-hydroxy-5,8-dimethoxyquinoline-3-carbonitrile(61338-35-0)
    12. EPA Substance Registry System: 4-hydroxy-5,8-dimethoxyquinoline-3-carbonitrile(61338-35-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 61338-35-0(Hazardous Substances Data)

61338-35-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 61338-35-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,3,3 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 61338-35:
(7*6)+(6*1)+(5*3)+(4*3)+(3*8)+(2*3)+(1*5)=110
110 % 10 = 0
So 61338-35-0 is a valid CAS Registry Number.

61338-35-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,8-dimethoxy-4-oxo-1H-quinoline-3-carbonitrile

1.2 Other means of identification

Product number -
Other names 3-Cyan-4-hydroxy-5,8-dimethoxy-chinolin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61338-35-0 SDS

61338-35-0Relevant articles and documents

USE OF CYANOQUINOLINES FOR TREATING OR INHIBITING COLONIC POLYPS

-

, (2008/06/13)

This invention provides a method of treating or inhibiting colonic polyps which comprises providing a compound of formula (1); wherein R1, R2, R3, R4, X, Y, and n are defined hereinbefore, or a pharmaceutically acceptable salt thereof.

SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS

-

Page 64, (2010/02/04)

This invention provides compounds of formula (1) wherein R1, G1, G2, R4, Z, X and n are defined herein, or a pharmaceutically acceptable salt thereof, which are useful as antineoplastic agents and in the treatment of polycystic kidney disease.

SUBSTITUTED 3-CYANO QUINOLINES

-

Page/Page column 79, (2008/06/13)

This invention provides compounds having formula (1), wherein: X is cycloalkyl which may be optionally substituted; or is a pyridinyl, pyrimidinyl, or phenyl ring; wherein the pyridinyl, pyrimidinyl, or phenyl ring may be optionally substituted; n is 0-1; Y is -NH-, -O-, -S-, or -NR-; R is alkyl of 1-6 carbon atoms; R1, R2, R3 and R4 are each, independently, hydrogen, halogen, alkyl, alkenyl, alkynyl, alkenyloxy, alkynyloxy, hydroxymethyl, halomethyl, alkanoyloxy, alkenoyloxy, alkynoyloxy, alkanoyloxymethyl, alkenoyloxymethyl, alkynoyloxymethyl, alkoxymethyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl, alkylsulfonamido, alkenylsulfonamido, alkynylsulfonamido, hydroxy, trifluoromethyl, cyano, nitro, carboxy, carboalkoxy, carboalkyl, phenoxy, phenyl, thiophenoxy, benzyl, amino, hydroxyamino, alkoxyamino, alkylamino, dialkylamino, aminoalkyl, N-alkylaminoalkyl, N,N-dialkylaminoalkyl, phenylamino, benzylamino, formulae (a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, p, q or r); R5 is alkyl which may be optionally substituted, or phenyl which may be optionally substituted; R6 is hydrogen, alkyl, or alkenyl; R7 is chloro or bromo; R8 is hydrogen, alkyl, aminoalkyl, N-alkylaminoalkyl, N,N-dialkylaminoalkyl, N-cycloalkylaminoalkyl, N-cycloalkyl-N-alkylaminoalkyl, N,N-dicycloalkylaminoalkyl, morpholino-N-alkyl, piperidino-N-alkyl, N-alkyl-piperidino-N-alkyl, azacycloalkyl-N-alkyl, hydroxyalkyl, alkoxyalkyl, carboxy, carboalkoxy, phenyl, carboalkyl +, chloro, fluoro, or bromo; Z is amino, hydroxy, alkoxy, alkylamino, dialkylamino, morpholino, piperazino, N-alkylpiperazino, or pyrrolidino; m = 1-4, q = 1-3, and p = 0-3; any of the substituents R1, R2, R3 or R4 that are located on contiguous carbon atoms can together be the divalent radical -O-C(R8)2-O-; or a pharmaceutically acceptable salt thereof with the proviso that when Y is -NH-, R1, R2, R3 and R4 are hydrogen, and n is O, X is not 2-methylphenyl, which are inhibitors of protein tyrosine kinase.

Method of treating or inhibiting colonic polyps

-

, (2008/06/13)

This invention provides a method of treating or inhibiting colonic polyps which comprises providing a compound of formula 1 wherein:R1, R2, R3, R4, X, Y, and n are as defined hereinbefore, or a pharmaceutically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 61338-35-0